DICP OpenIR
Subject Area分析化学
Serum lipid profiling of patients with chronic hepatitis B, cirrhosis and hepatocellular carcinoma by ultra fast liquid chromatography/ion trap-time of flight mass spectrometry
Chen SL(陈世礼); Yin PY(尹沛源); Zhao XJ(赵欣捷); WenbinXing; Hu CX(胡春秀); Zhou LN(周丽娜); Xu GW(许国旺)
Source PublicationProceeding of HPLC 2011
Conference Name37th International Symposium on High Performance Liquid Phase Separations and Related Techniques
Conference Date2011-10-8
2011
Conference Place大连
Pages721-0
Publisher待补充
Publication Place待补充
Cooperation Status墙报
Department1808
Funding Organization中国化学会色谱专业委员会
AbstractAn ultra fast liquid chromatography/ion trap-time of flight mass spectrometry (UFLC/MS-IT-TOF) based serum lipidomics platform was developed to characterize the serum lipid profile of patients with Chronic Hepatitis B (CHB), Cirrhosis, Hepatocellular Carcinoma (HCC) and normal controls. CH3OH/CH2Cl2/H2O solvent mixture was employed to extract lipids from serum, which was simple and reproducible. Reversed-phase liquid chromatography was used to separate the lipids according to their hydrophobicity, possessing the advantage of retention time stability than normal-phase liquid chromatography. Detection was performed on Ion Trap-Time of Flight Mass Spectrometry, which provided high sensitivity to detect low-content lipid component and high accurate m/z to facilitate lipid identification. After data collection and processing, 96 lipids within five species were identified including lysophosphatidylcholines, phosphatidylcholines, sphingomyelins, triacylglycerides and cholesterol esters. Heatmap and multivariate analysis methods PCA and PLS-DA were used to overview the lipid profile relationship between CHB, Cirrhosis, HCC patients and normal controls. CHB patients and healthy controls had similar serum lipid profile, but some differences still existed. Cirrhosis and HCC patients had similar serum lipid profile, and both were different from normal controls or even CHB patients. When ANOVA test was performed, Cirrhosis and HCC patients had many significantly decreased serum lipids compared with CHB patients or the controls. CHB also induced several serum lipids significantly altered in patients compared with normal controls, however very few lipid metabolites were differently expressed in HCC when compared with Cirrhosis patients. The univariate analysis results confirmed the heatmap and multivariate results, and all indicated the mild liver injury in CHB patients and severe injury severity in Cirrhosis and HCC patients. This work demonstrated the utility of LC/MS-based serum lipidomics platform as a powerful tool to investigate the pathogenesis and development of HBV-related liver diseases.; An ultra fast liquid chromatography/ion trap-time of flight mass spectrometry (UFLC/MS-IT-TOF) based serum lipidomics platform was developed to characterize the serum lipid profile of patients with Chronic Hepatitis B (CHB), Cirrhosis, Hepatocellular Carcinoma (HCC) and normal controls. CH3OH/CH2Cl2/H2O solvent mixture was employed to extract lipids from serum, which was simple and reproducible. Reversed-phase liquid chromatography was used to separate the lipids according to their hydrophobicity, possessing the advantage of retention time stability than normal-phase liquid chromatography. Detection was performed on Ion Trap-Time of Flight Mass Spectrometry, which provided high sensitivity to detect low-content lipid component and high accurate m/z to facilitate lipid identification. After data collection and processing, 96 lipids within five species were identified including lysophosphatidylcholines, phosphatidylcholines, sphingomyelins, triacylglycerides and cholesterol esters. Heatmap and multivariate analysis methods PCA and PLS-DA were used to overview the lipid profile relationship between CHB, Cirrhosis, HCC patients and normal controls. CHB patients and healthy controls had similar serum lipid profile, but some differences still existed. Cirrhosis and HCC patients had similar serum lipid profile, and both were different from normal controls or even CHB patients. When ANOVA test was performed, Cirrhosis and HCC patients had many significantly decreased serum lipids compared with CHB patients or the controls. CHB also induced several serum lipids significantly altered in patients compared with normal controls, however very few lipid metabolites were differently expressed in HCC when compared with Cirrhosis patients. The univariate analysis results confirmed the heatmap and multivariate results, and all indicated the mild liver injury in CHB patients and severe injury severity in Cirrhosis and HCC patients. This work demonstrated the utility of LC/MS-based serum lipidomics platform as a powerful tool to investigate the pathogenesis and development of HBV-related liver diseases.
Document Type会议论文
Identifierhttp://cas-ir.dicp.ac.cn/handle/321008/116081
Collection中国科学院大连化学物理研究所
Corresponding AuthorXu GW(许国旺)
Recommended Citation
GB/T 7714
Chen SL,Yin PY,Zhao XJ,et al. Serum lipid profiling of patients with chronic hepatitis B, cirrhosis and hepatocellular carcinoma by ultra fast liquid chromatography/ion trap-time of flight mass spectrometry[C]. 待补充:待补充,2011:721-0.
Files in This Item:
There are no files associated with this item.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
Google Scholar
Similar articles in Google Scholar
[陈世礼]'s Articles
[尹沛源]'s Articles
[赵欣捷]'s Articles
Baidu academic
Similar articles in Baidu academic
[陈世礼]'s Articles
[尹沛源]'s Articles
[赵欣捷]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[陈世礼]'s Articles
[尹沛源]'s Articles
[赵欣捷]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.